PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.4950
+0.0150 (3.13%)
Aug 11, 2025, 4:00 PM EDT
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 54.19 million as of August 14, 2025. Its market cap has increased by 1,254.72% in one year.
Market Cap
54.19M
Enterprise Value
42.40M
Revenue
9.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 54.19M, an increase of 2,157.87%. That is a compound annual growth rate of 195.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 54.19M | -14.45% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.90B |
| Green Thumb Industries | 2.71B |
| Trulieve Cannabis | 2.06B |
| Sienna Senior Living | 1.73B |
| dentalcorp Holdings | 1.63B |
| Cronos Group | 1.40B |
| WELL Health Technologies | 1.22B |
| Extendicare | 1.11B |